Third Wave Technologies, Inc.'s Inplex(TM) CF Molecular Test Receives FDA Clearance

March 14 (Reuters) - Third Wave Technologies Inc (TWTI.O: Quote, Profile, Research) said the U.S. Food and Drug Administration cleared the diagnostics company’s test, called InPlex CF Molecular Test, that detects and identifies cystic fibrosis mutations in DNA samples.

MORE ON THIS TOPIC